Prolonged use of carbapenems and colistin predisposes to ventilator-associated pneumonia by pandrug-resistant Pseudomonas aeruginosa-Reference-Cited by-同舟云学术

Prolonged use of carbapenems and colistin predisposes to ventilator-associated pneumonia by pandrug-resistant Pseudomonas aeruginosa

Published:2007-06-05 Issue:9 Volume:33 Page:1524-1532
ISSN:0342-4642
Container-title:Intensive Care Medicine
language:en
Short-container-title:Intensive Care Med

Author:

Mentzelopoulos Spyros D.,Pratikaki Maria,Platsouka Evangelia,Kraniotaki Helen,Zervakis Dimitris,Koutsoukou Antonia,Nanas Serafim,Paniara Olga,Roussos Charis,Giamarellos-Bourboulis Evangelos,Routsi Christina,Zakynthinos Spyros G.

Publisher

Springer Science and Business Media LLC

Subject

Critical Care and Intensive Care Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00134-007-0683-2.pdf

Reference36 articles.

1. Ferrara AM (2006) Potentially multidrug-resistant non-fermentative Gram-negative pathogens causing nosocomial pneumonia. Int J Antimicrob Agents 27:183–195

2. Murray CK, Hospenthal DR (2005) Treatment of multidrug resistant Acinetobacter. Curr Opin Infect Dis 18:502–506

3. Obritsch MD, Fish DN, Maclaren R, Jung R (2005) Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options. Pharmacotherapy 25:1353–1364

4. Falagas ME, Blitziotis IA, Kasiakou SK, Samonis G, Athnassopoulou P, Michalopoulos A (2005) Outcome of infections due to pandrug-resistant (PDR) gram-negative bacteria. BMC Infect Dis 5:24–31

5. Routsi C, Platsouka E, Willems RJL, Bonten MJ, Paniara O, Saroglou G, Roussos C (2003) Detection of enterococcal surface protein gene (esp) and amplified length polymorphism typing of glycopeptide-resistant Enterococcus faecium during its emergence in a greek intensive care unit. J Clin Microbiol 41:5472–5746

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-Dose Nebulized Colistin Methanesulfonate and the Role in Hospital-Acquired Pneumonia Caused by Gram-Negative Bacteria with Difficult-to-Treat Resistance: A Review;Microorganisms;2023-05-31

2. Evaluating the impact of de-escalating antimicrobial therapy in burn patients: a retrospective cohort study;PHARMAZIE;2022

3. Losing the Battle but Winning the War: Can Defeated Antibacterials Form Alliances to Combat Drug-Resistant Pathogens?;Antibiotics;2021-05-28

4. Clinical Pharmacology of Bacteriophage Therapy: A Focus on Multidrug-Resistant Pseudomonas aeruginosa Infections;Antibiotics;2021-05-11

5. Intrapulmonary concentrations of meropenem administered by continuous infusion in critically ill patients with nosocomial pneumonia: a randomized pharmacokinetic trial;Critical Care;2020-02-17